Associate Professor (Status-only)
I am currently a Pharmacy Clinician Scientist/Associate Professor at the University Health Network/Leslie Dan Faculty of Pharmacy, University of Toronto. My main practice, teaching and research site has been the hemodialysis unit / nephrology at the University Health Network where I oversee the provision of pharmaceutical care to over 400 patients.
I am currently involved in a variety teaching activities at various levels at the Leslie Dan Faculty of Pharmacy, University of Toronto. I serve as a clinical rotation preceptor for PharmD, SPEP students and pharmacy residents as well as a therapeutics case study coordinator for undergraduate and IPG students. I am known for “pyramid teaching”, a model where I take on PharmD students, pharmacy residents and SPEP students at the same time to foster students systematically mentoring other students.
My clinical pharmacy research interests include: anemia and bone disease management in the chronic kidney disease (CKD) population, specifically investigating newer agents being utilized to treat these disease states and protocol driven practices. Another area of my pharmacy practice research in nephrology is vascular access. Areas of research include access related infections, specifically understanding infection rates, organisms involved and locking devices for catheters and their clinical outcomes. Furthermore dialysis modalities have evolved and the pharmacokinetics of drugs has also changed. Therefore much of my research has focused on drug clearance with these newer modalities. Lastly, another area of my research is pharmacy practice research. Here we have investigated different pharmacy services for the dialysis patient and outcomes. I have been the lead investigator on a number of research projects in these areas. Please refer to list of publications for the scope of my clinical research.
- Battistella, M. ABCs of Common Anemias. Pharmacy Practice Sept 2008; 24 (7): 35-42.
- Batistella M, Ghazi H, Wong M, Hamandi B, Richardson RM. Significant Cost Savings in Hemodialysis Patients Converted From Intravenous Erythropoietin to Darbepoetin While Maintaining Hemoglobin in Target Range. Poster Presentation: American Society of Nephrology Annual General Meeting. November 2006. San Diego California. Journal of American Society of Nephrology 2006.
- Charlesworth E, Richardson, RM, Battistella M. Cost Savings After Implementation of an Anemia Management Protocol in a Hemodialysis Unit. American Society of Nephrology Annual General Meeting. November 2010. Denver, Colorado. Journal of American Society of Nephrology 2010.
- Sood MM, Battistella M, Lok, CE. Patterns of cardioprotective medication prescription in incident hemodialysis patients. International Urology and Nephrology. 2009; 41 (4): 1021-1027.
- Sood M, Battistella M, Lok C, Richardson R. Prevalence of White Coat Effect in Hemodialysis Patients as Determined by Standardized Automated Blood Pressure Measurement. Poster Presentation: American Society of Nephrology Annual General Meeting. November 2007. San Francisco, California. Journal of American Society of Nephrology 2007.
- Battistella M, Hunchuck J, Wong E, Hladewunich M, McLeod A, Chan, C. Use of fondaparinux as an anticoagulant during nocturnal hemodialysis in a pregnant patient. Poster presentation at the Canadian Society of Nephrology Annual Meeting, Montreal, Quebec, May 28-30, 2010.
- Battistella M, Hamandi B, Richardson RM. Vancomycin Dosing in Patients Receiving High-Flux Hemodialysis. Canadian Society of Nephrology Annual General Meeting. May 2008. London, Ontario Canada.
- Harrison J, Niven A, Battistella M, Richardson R, Lewis K, Walker S and Husain S. Pharmacokinetics of ganciclovir in solid organ transplant recipients on high flux-high efficiency hemodialysis. Poster presentation at Canadian Society of Transplantation Annual Scientific Conference, March 2011.
- Harrison J, Niven A, Battistella M, Richardson R, Lewis K, Walker S and Husain S. Pharmacokinetics of ganciclovir in solid organ transplant recipients on high flux-high efficiency hemodialysis. Am J Transplant 2011; 11(s2): 457. Poster presentation at the American Transplant Congress Meeting, May 2011.
- Battistella M, Volling J, Ingram S, Joarder, M, Richardson R. The Impact of Medication Reconciliation in an Ambulatory Hemodialysis Clinic. Poster Presentation World Congress of Nephrology, April 8-12 2011, Vancouver, British Columbia, Canada. Nephrology Dialysis and Transplantation 2011.
- Battistella M, Jassal V, Oreopolous D, Richardson RM. Cinacalcet is Effective in Patients with PTH > 100pmol/l. Nephrology Dialysis and Transplantation 2008;23:773-774.
- Battistella M, Bargman J, Richardson R, Chan, C: Improved Hyperparathyroid Control By Cinacalcet Ameliorates Erythropoietin Responsiveness in Patients with End-Stage Renal Disease. Clinical Nephrology 2011; 76(2):99-103.
- Battistella M, Walker S, Lau S, Lok C. Antibiotic Lock: In Vitro Stability of Vancomycin and 4% Trisodiun Citrate Stored in Dialysis Catheters, Hemodialysis International 2009; 13:322-328.
- Battistella M, Vercainge LM, Cote, D, Lok C: Antibiotic Lock: In Vitro Stability of Gentamicin and Sodiun Citrate Stored in Dialysis Catheters at 37ºC. Hemodialysis International 2010; 14:322-326.
- Battistella M, Bhola C, Lok CE: Long-term Follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: A Quality Improvement Report. Am J Kidney Disease 2011;57(3) 432-441.
University Health Network
200 Elizabeth St EB 214
Toronto, Ontario, M5G 2C4
Tel: 416-340-4800 x3207